A Study of LY900014 in a Medtronic Pump

Inclusion Criteria:

- Participants must have been diagnosed with type 1 diabetes and have been using insulin
continuously for at least 12 months

- Participants must be using an insulin pump with "rapid-acting insulin" for at least 6
months and the same "rapid acting insulin" for at least the past 30 days

- Participants must have hemoglobin A1c (HbA1c) values ≥6.0% and ≤8.0%

- Participants must have been using the MiniMed 670G insulin pump for at least the past
90 days

- Participants must use their Guardian (3) sensor at least an average of 75% of the time
and remain in Auto Mode an average of 70% of the time

Exclusion Criteria:

- Participants must not have had more than 1 emergency treatment for very low blood
glucose or any hospitalizations for poor glucose control (very high blood sugar or
diabetic ketoacidosis) in the last 6 months

- Participants must not have significant abnormal accumulation of fat, loss of fat
tissue, or scars just under the skin in areas of infusion or have a history of an
infection at an infusion site within 90 days prior to screening

- Participants must not have a total daily insulin dose >100 units

- Participants must not be receiving any oral or injectable medication intended for the
treatment of diabetes other than rapid-acting analog insulin via CSII in the 30 days
prior to screening

- Participants must not have major problems with their heart, kidneys, liver, or have a
blood disorder